Epigallocatechin gallate from green tea effectively blocks infection of sars-cov-2 and new variants by inhibiting spike binding to ace2 receptor

HIGHLIGHTS

• who: Jinbiao Liu from the Department of Pathology and Laboratory Medicine, Center University Lewis Katz School of Medicine, Philadelphia, PA, USA have published the research: Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor, in the Journal: (JOURNAL) of August/13,/2021
• what: The authors examined whether green tea beverage (GTB) and the tea catechins (EGCG, EGC, ECG and EC) can inhibit infection of live SARS-CoV-2 and the pseudoviruses with spikes of the newly emerged variants (UK-B.1.1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.